This #LabWeek, we celebrate all labs working hard to save patients’ lives, from our lab team in Denmark creating our NGAL products to our customer labs using NGAL to identify and manage acute kidney injury. #ASCPLabWeek25 #LabsSaveLives #GlobalMedLabWeek EFLM

AKI in pediatric solid organ transplant patients is common, affecting 37-57%, depending on the type of transplanted organ. Ask us how BioPorto’s NGAL tests can help you assess #AKI risk in these vulnerable patients. #KidsTransplantWeek #NGAL4kids

Join the ISCCN community for research, education, and professional development dedicated to critical care nephrology. 📸 Lui Forni – founder & board member Mitra Nadim, MD – early joiner Join today at isccn.org

We are excited to see #AKI on the program at EuroMedLab 2025. Don’t miss sessions by Joe M. El-Khoury, PhD, DABCC and Marlies Ostermann. While you’re there, connect with JenZ of BioPorto (NGAL) to learn more about BioPorto’s NGAL tests for earlier AKI identification and management, and our ongoing adult clinical

Learn from pediatric intensivists worldwide how innovation, teamwork, and smarter technology are reshaping care in #PedsICU. We celebrate our collaborations with global #PICU teams every day – thank you for all you do to advance care and improve outcomes in your patients.

The critical care community has lost a great innovator and leader in AKI and biomarkers. He will be missed by many.

👏🎉Today, we celebrate World PICU Awareness Day by recognizing the PICU teams worldwide for their relentless efforts in driving impactful and innovative solutions for continued improvement in pediatric critical care. #CritCareMonth #WPAW25 #PedsICU WFPICCS @ESPNIC

AKI commonly occurs in critically ill children, but its impact on pediatric growth outcomes has been sparsely described. Read this Systematic Review /Meta-analysis comparing growth in children w/a history of AKI to those w/o AKI. #OpenAccess link.springer.com/article/10.100…

Knowledge of #AKI risks can help care teams manage their patients and help avoid poor outcomes. newsweek.com/hospitals-most… Newsweek

Today, we celebrate #ICU teams worldwide for their collaboration to drive technological and therapeutic advances while delivering compassionate, quality, patient-centered, and personalized care. #CritCareMonth #BlueICU ICU Management SCCM Critical Care Medicine ESPNIC

BioPorto's Ray White is attending #NTI2025. Connect with him to learn how NGAL testing can help you be a kidney hero – identify and manage #AKI earlier to reduce or prevent kidney damage. #NGAL4kids

Headed to #ESPNIC2025? Don’t miss our June 26th lunch symposium. Learn how the NGAL biomarker can help you manage fluids and AKI in your critically ill patients, including the latest research on the use of NGAL for RRT liberation. #NICU #PICU #NGAL4kids ESPNIC

The BioPorto team will be in Alicante and available to meet at #ESPNIC2025. Reach out to put a meeting on the calendar, stop by stand 23 to say hello, or join our lunch symposium to learn how NGAL can help you improve AKI and fluid management.👇 ESPNIC

Don’t miss Prof. Shacham’s poster presentation at #43VicenzaCourse where he will share how NGAL can aid in early risk stratification for STEMI patients at risk of AKD. This is a great opportunity to learn how NGAL can help improve patient outcomes. #KidneyHealthForAll #AKD

#ESPNIC2025 is just a few days away. Be sure to join our symposium for lunch and learn about NGAL for managing fluids in your critically ill patients at risk of AKI. Connect with Cristiane de Souza Carvalho Wodarz in a session or visit us at stand 23 in the exhibit hall. ESPNIC #NGAL4kids

We are excited to be part of #ADLM2025. Visit us at booth 5327 for an update on ProNephro AKI and our adult clinical study. Learn more about NGAL testing for earlier AKI risk assessment. See you in Chicago!

Attending #NeoHeart2025 in San Diego? Let’s talk about NGAL for earlier AKI assessment in your patients. Discover how this biomarker offers an additional data point to inform your care decisions earlier and with confidence. #NGAL4kids #NGAL4AKI

Don’t miss these #ADLM2025 sessions. Learn about renal biomarkers for the early prediction and management of acute kidney injury. Visit booth 5327 to learn about BioPorto’s NGAL tests. #NGAL4AKI #NGAL4kids Association for Diagnostics & Laboratory Medicine

BioPorto is excited to attend #NeoHeart2025. Stop by table 4 to learn about the #NGAL biomarker to manage #AKI in your patients. See you in San Diego! #NGAL4kids #NICU #PCICU